You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Archive for July, 2014

EAHP congress podcasts

9 Jul, 14 | by ltempler

The podcasts are finally up and ready to be heard in several different languages. Here’s a run down of who and what you can listen to and links through to the SoundCloud page.

1. Sotiris Antoniou, consultant pharmacist for cardiovascular medicine at Barts Health NHS Trust, talks through the importance of anticoagulation, and how to consult patients. Listen here >>

2. Matthieu Tjoeng, head of pharmacy at Sint Antonius Ziekenhuis, Anne Spinewine, clinical pharmacist at UCL and CHU Dinant Godinne, and Steve Williams, associate editor of EJHP and honorary clinical lecturer at University Hospital of South Manchester, discuss re-engineering clinical pharmacy services. Listen here >>

3. Dr Juraj Sykora works at the National Cancer Institution, is an associate editor of EJHP and faculty member for EAHP. Here he discusses EAHP 2014, innovation and biosimilars. This podcast is in Slovak. Listen here >>

4. Dr Juraj Sykora, National Cancer Institution, associate editor of EJHP, and faculty member of EAHP, discusses the formation of a common training framework. Listen here >>

5. Piera Polidori lavora all’ISMETT ed è coredattrice di EJHP. In questo podcast descrive un nuovo progetto italiano in cui è coinvolta sul ruolo del farmacista clinico nella gestione degli antimicrobici. A seguito di un progetto del 2010 con il Ministero della Sanità, l’EAHP e la società italiana di oncologia, quest’anno la SIFO – Società Italiana di Farmacia Ospedaliera promuove il nuovo progetto a supporto dello sviluppo della farmacia clinica in Italia.

Simona Creazzola è farmacista presso l’ASL Napoli 1 Centro. È membro del Consiglio Direttivo della SIFO, la società italiana che rappresenta i farmacisti ospedalieri nel Sistema Sanitario Nazionale, e collabora alla redazione dell’EJHP. Simona ci è venuta a parlare del nuovo Laboratorio HTA della SIFO. Il Laboratorio HTA punta a raccogliere le esperienze passate nel campo HTA – Health Technology Assesment sui farmaci e dispositivi medici per costruire un’importante struttura per la divulgazione della cultura della valutazione sistematica tra gli associati attraverso gli strumenti corretti.  Ascolta qui >>

6. Duncan McRobbie, associate chief pharmacist at Guy’s and St Thomas’ NHS Trust Foundation, talks about un-intentional and intentional reasons for not taking or continuing a prescription. Listen here >>

7. Roberto Frontini, director of pharmacy, University of Leipzig, and president, EAHP, explains the focus of the EAHP European Summit on Hospital Pharmacy in May. He also talks about how pharmacists can work with and engage clinicians and other hospital staff. Listen here >>

8. Roberto Frontini, director of pharmacy, University of Leipzig, and president, EAHP, discusses the future of hospital pharmacy, and how the profession may look in 2020. Listen here >>

9. Cees Neef, professor of clinical pharmacy, Maastrict University Medical Centre, and director of education, Science and Research, EAHP, explains Good Practice Indicators. Listen here >>

10. Professor Daan Crommelin, past scientific director of the Dutch Top Institute Pharma in Leiden and emeritus professor, Department of Pharmacists, Utrecht University, discusses the Innovative Medicines Initiative, and developing innovation in pharmacy. Listen here >>

 


 

Apps involving medicines should have pharmacist oversight

9 Jul, 14 | by ltempler

The European Association of Hospital Pharmacists (EAHP) has responded to a consultation by the European Commission advising that any mHealth applications linked to the use of medicines must have levels of regulatory oversight, ideally involving pharmacist expertise, in order to ensure their safety.

The European Commission launched a consultation on mHealth in April 2014, asking healthcare professionals and patients for input on the health related applications of smartphone technology. One of EAHP’s key points was that the introduction of new technologies in the hospital setting has been an ever-present reality. Lessons learned include the need to understand the potential positive applications of a new technology at an early stage, and for Governments and health system managers to take a leadership role in achieving their realisation. This lesson, for example, is evident in the difficulties experienced in achieving bedside scanning as a patient safety measure within hospital systems – as medicines still do not typically contain a bar code to the single unit.

Another key point of EAHP’s response was to underline safety needs when applying mHealth to any process involving medicines.

Dr Roberto Frontini, President of the European Association of Hospital Pharmacists, said:

“The implications of a badly designed mHealth application related to medicines use is frightening. All medicines can potentially cause harm if not taken properly. Therefore, when it comes to mHealth apps and medicines, a level of regulatory oversight is required. We recommend pharmacists be involved in both development and testing of such applications.  Indeed, the need for such pharmacist involvement in ICT processes involving medicines was a strong component of the recently published European Statements of Hospital Pharmacy, agreed with patient organisations and other healthcare professionals.

Beyond this, we urge the European Commission to learn lessons of experience. Technology can offer so much. However, without both vision to see potential positive applications, and subsequent coordination, too often the benefits are not realised. We see this, for example, with our ongoing campaign to achieve bedside scanning of medicines in hospitals. Barriers and obstacles have to be identified and lifted. There is an important coordinating role for the Commission in this regard.

Finally, we urge the Commission not to think about mHealth as only having cost-saving benefits. Improved patient safety and patient outcomes must be considered as just as important, if not more so.”

 

This information has been taken from the EAHP website, more information can be found here

Latest from European Journal of Hospital Pharmacy

Latest from European Journal of Hospital Pharmacy